• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

DNA sequencing may inform diagnosis and management of kidney disease

byCaitlyn HuiandDeepti Shroff Karhade
December 8, 2017
in Chronic Disease, Nephrology, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Whole exome sequencing (WES) provided diagnosis for a subset of patients with chronic kidney disease (CKD).

2. Identification of certain mutations, via WES, changed the clinical management of CKD patients.

Evidence Rating Level: 2 (Good)

Study Rundown: Over the past 10 years, we have seen significant advances in genetics technology that allows us to better understand the cause and potential treatments of various diseases. CKD is one such condition that DNA sequencing may greatly influence the diagnosis and management. While there is significant morbidity and mortality related to CKD, early-stage CKD tends to be clinically silent. Diagnosing CKD at an earlier stage may have beneficial impacts in terms of patient prognosis. The authors of this study aimed to assess the diagnostic utility of WES in CKD and its potential effect on clinical management. In general, they observed that through applying WES to patients with CKD of unknown cause, they were able to determine diagnostic mutations. This study has several limitations. Of note, the study had a small sample size and therefore cannot be generalized to CKD patients on a population level. By conducting WES analysis of more diverse cohorts of CKD, the authors will obtain information regarding the applicability of WES to the broader CKD population and its overall diagnostic yield in nephrology practice. The results of this study suggest that WES may be of clinical utility to the diagnosis and management of CKD in the future.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: Exploring the genetic basis of early-onset chronic kidney disease

In-Depth [prospective cohort]: In this observational pilot study, the authors included 92 adult patients with CKD with a clinical diagnosis either compatible with a Mendelian genetic disease, a familial nephropathy of unclear cause, or unexplained kidney failure. These participants were selected from a group of 344 patients from outpatient nephrology clinics. WES was applied to these participants and a panel of nephrologists and molecular geneticists interpreted the data. In total, the authors observed that 24% of patients (22 out of 92) received a diagnosis through using WES. Several important mutations were observed, including loss-of-function mutations in the gene PARN. Identifying these genetic diagnoses resulted in specific changes to patient’s medical management, including alteration of treatment, increasing screening for certain conditions, and providing incentive to screen family members.

RELATED REPORTS

ACKR1 variant increases risk of azathioprine-related hematopoietic toxicity

#VisualAbstract: Whole-genome sequencing changes clinical management in significant number of critically ill infants

Psychological experiment suggests genetic testing may influence neonatologists’ clinical decision-making

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: genetic testinggeneticswhole genome sequencing (WGS)
Previous Post

Long-term comorbidities in extremely preterm infants with cerebral palsy

Next Post

Value-based payment modifier program not associated with differences in performance program measures

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

ACKR1 variant increases risk of azathioprine-related hematopoietic toxicity

June 30, 2022
#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication
StudyGraphics

#VisualAbstract: Whole-genome sequencing changes clinical management in significant number of critically ill infants

June 10, 2022
Pediatric palliative care outcome measures often miss quality of life
Chronic Disease

Psychological experiment suggests genetic testing may influence neonatologists’ clinical decision-making

February 16, 2022
Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Chronic Disease

Whole-genome sequencing changes clinical management in significant number of critically ill infants

December 21, 2021
Next Post
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Value-based payment modifier program not associated with differences in performance program measures

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Pharmacomechanical thrombolysis does not lower risk of post-thrombotic syndrome: The ATTRACT trial

Recombinant viral vector treatment sustains endogenous factor IX activity in patients with hemophilia B

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.